{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:54:19Z","timestamp":1774896859103,"version":"3.50.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.semarthrit.2008.08.003","type":"journal-article","created":{"date-parts":[[2008,12,4]],"date-time":"2008-12-04T11:13:29Z","timestamp":1228389209000},"page":"132-143","source":"Crossref","is-referenced-by-count":58,"title":["Systemic Nonarticular Manifestations of Rheumatoid Arthritis: Focus on Inflammatory Mechanisms"],"prefix":"10.1016","volume":"39","author":[{"given":"Larry W.","family":"Moreland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2008.08.003_bib1","first-page":"62","article-title":"Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis","volume":"29","author":"Turesson","year":"2002","journal-title":"J Rheumatol"},{"issue":"Suppl 7A","key":"10.1016\/j.semarthrit.2008.08.003_bib2","doi-asserted-by":"crossref","first-page":"50S","DOI":"10.1016\/j.amjmed.2003.12.012","article-title":"Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature","volume":"116","author":"Wilson","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years","volume":"62","author":"Turesson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","article-title":"Rheumatoid arthritis","volume":"85","author":"Feldmann","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0049-0172(95)80034-4","article-title":"Pulmonary involvement in rheumatoid arthritis","volume":"24","author":"Anaya","year":"1995","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/rheumatology\/32.3.209","article-title":"Extra-articular manifestations are uncommon in southern Chinese with rheumatoid arthritis","volume":"32","author":"Cohen","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib7","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/ard.2003.016014","article-title":"A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate","volume":"63","author":"Cohen","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/ar1373","article-title":"Adverse effects of rheumatoid arthritis on bone remodeling","volume":"6","author":"Goldring","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib9","first-page":"1504","article-title":"Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease","volume":"24","author":"Jongen-Lavrencic","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib10","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/rheumatology\/kel021","article-title":"Fatigue in rheumatoid arthritis reflects pain, not disease activity","volume":"45","author":"Pollard","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/rheumatology\/37.10.1042","article-title":"Fatigue in rheumatoid arthritis: the role of self-efficacy and problematic social support","volume":"37","author":"Riemsma","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/rheumatology\/38.7.668","article-title":"Extra-articular rheumatoid arthritis: prevalence and mortality","volume":"38","author":"Turesson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib13","first-page":"2115","article-title":"Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients","volume":"31","author":"Wolfe","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib14","first-page":"1516","article-title":"Anemia and renal function in patients with rheumatoid arthritis","volume":"33","author":"Wolfe","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/art.10705","article-title":"Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years","volume":"48","author":"Gabriel","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/clim.1999.4736","article-title":"Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis","volume":"92","author":"Voulgari","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00463-3","article-title":"Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?","volume":"148","author":"Yudkin","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2007.06.013","article-title":"Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue","volume":"22","author":"Davis","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib19","first-page":"1673","article-title":"Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes","volume":"32","author":"Glossop","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib20","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/art.11294","article-title":"Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis","volume":"48","author":"Maury","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1182\/blood-2002-01-0136","article-title":"Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy","volume":"100","author":"Papadaki","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib22","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood-2002-04-1260","article-title":"Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease","volume":"100","author":"Weinstein","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ncpgasthep0019","article-title":"Mechanisms of disease: the role of hepcidin in iron homeostasis\u2014implications for hemochromatosis and other disorders","volume":"1","author":"Pietrangelo","year":"2004","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib24","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib25","first-page":"2430","article-title":"Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis","volume":"28","author":"Kaltwasser","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib26","first-page":"18","article-title":"Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia","volume":"33","author":"Mercuriali","year":"1996","journal-title":"Semin Hematol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib27","first-page":"2177","article-title":"Association of anemia and physical disability among patients with rheumatoid arthritis","volume":"34","author":"Han","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02230334","article-title":"Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate","volume":"15","author":"Franck","year":"1996","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/qjmed\/94.6.309","article-title":"Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice","volume":"94","author":"Grove","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib30","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s10067-006-0229-y","article-title":"A case report of tumor necrosis factor-alpha antibody-induced thrombocytopenia associated with emerging IgM anticardiolipin antibody in patients with scleroderma overlap\/rheumatoid arthritis","volume":"26","author":"Hamaguchi","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib31","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/rheumatology\/kel204","article-title":"TNFalpha blocker-induced thrombocytopenia","volume":"45","author":"Pathare","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib32","first-page":"1174","article-title":"Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis","volume":"34","author":"Kirwan","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/art.22611","article-title":"Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use","volume":"57","author":"Hewlett","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib34","first-page":"1496","article-title":"Psychosocial variables and fatigue: a longitudinal study comparing individuals with rheumatoid arthritis and healthy controls","volume":"33","author":"Mancuso","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib35","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.22033","article-title":"Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in european patients with rheumatoid arthritis who had an incomplete response to methotrexate","volume":"54","author":"Maini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.21838","article-title":"Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis","volume":"55","author":"Moreland","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.10697","article-title":"Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial","volume":"48","author":"Weinblatt","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib38","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","article-title":"A meta-analysis of prior corticosteroid use and fracture risk","volume":"19","author":"Kanis","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib39","first-page":"185","article-title":"Inflammatory cell infiltrate and RANKL\/OPG expression in rheumatoid synovium: comparison with other inflammatory arthropathies and correlation with outcome","volume":"23","author":"Fonseca","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib40","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(02)00915-8","article-title":"Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism","volume":"32","author":"Kudo","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib42","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/41.9.972","article-title":"Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage","volume":"41","author":"Abramson","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib43","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(88)90185-7","article-title":"Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis","volume":"2","author":"Eastgate","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib44","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.bone.2004.07.004","article-title":"TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis","volume":"35","author":"Saidenberg-Kermanac'h","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10165-006-0531-1","article-title":"Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis","volume":"17","author":"Suematsu","year":"2007","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib46","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1074\/jbc.M510156200","article-title":"MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase","volume":"281","author":"Kim","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2007.073817","article-title":"Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis","volume":"67","author":"Guler-Yuksel","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/ard.2007.076604","article-title":"Long term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis","volume":"67","author":"Chopin","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib49","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2165\/00063030-199707050-00003","article-title":"Felty's syndrome","volume":"7","author":"Pixley","year":"1997","journal-title":"BioDrugs"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib50","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/art.1780400405","article-title":"T cell receptor alpha-chain and beta-chain junctional region homology in clonal CD3+, CD8+ T lymphocyte expansions in Felty's syndrome","volume":"40","author":"Bowman","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib51","first-page":"285","article-title":"The role of interleukin-8 and other cytokines in the pathogenesis of Felty's syndrome","volume":"13","author":"Meliconi","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib52","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/ard.2004.025643","article-title":"Lack of efficacy of rituximab in Felty's syndrome","volume":"64","author":"Sordet","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib53","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2004.032110","article-title":"Etanercept in treatment of Felty's syndrome","volume":"64","author":"Ghavami","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib54","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"del Rincon","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib55","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/ard.2003.018101","article-title":"Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study","volume":"63","author":"Turesson","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.2006.052506","article-title":"Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis","volume":"66","author":"Turesson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib57","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/art.22912","article-title":"Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample","volume":"57","author":"De Pablo","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-144-4-200602210-00006","article-title":"Preclinical carotid atherosclerosis in patients with rheumatoid arthritis","volume":"144","author":"Roman","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib59","doi-asserted-by":"crossref","first-page":"R634","DOI":"10.1186\/ar1717","article-title":"Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis","volume":"7","author":"Dessein","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib60","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1001\/jama.286.17.2107","article-title":"Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy","volume":"286","author":"Lindmark","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib61","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib62","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1196\/annals.1422.038","article-title":"Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors","volume":"1108","author":"Gerli","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib63","first-page":"2311","article-title":"Lipid profiles among US elderly with untreated rheumatoid arthritis\u2014the third National Health and Nutrition Examination Survey","volume":"32","author":"Choi","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib64","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.62.9.842","article-title":"Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis","volume":"62","author":"Boers","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2005.08.010","article-title":"Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis","volume":"365","author":"Allanore","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib66","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/ard.2004.023119","article-title":"Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis","volume":"64","author":"Popa","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib67","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1196\/annals.1351.039","article-title":"Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis","volume":"1069","author":"Seriolo","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib68","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10067-007-0539-8","article-title":"Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis","volume":"26","author":"Tam","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib69","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2045","article-title":"Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study","volume":"8","author":"van Halm","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib70","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","article-title":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis","volume":"106","author":"Hurlimann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib71","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib72","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib73","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/art.21628","article-title":"Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations","volume":"54","author":"Liang","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.2006.059980","article-title":"Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-RA patients?","volume":"67","author":"Gonzalez","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib75","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/bjo.87.5.548","article-title":"Tumour necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations","volume":"87","author":"Prada","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib76","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.rhu.0000249766.24780.95","article-title":"Rheumatoid arthritis-associated necrotizing scleritis and peripheral ulcerative keratitis treated successfully with infliximab","volume":"12","author":"Atchia","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib77","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ajo.2005.05.025","article-title":"Correlation between dry eye and rheumatoid arthritis activity","volume":"140","author":"Fujita","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib78","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","article-title":"Pulmonary involvement in rheumatoid arthritis","volume":"25","author":"Bilgici","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib79","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.20765","article-title":"Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis","volume":"52","author":"Turesson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib80","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/art.21758","article-title":"Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia","volume":"54","author":"Atkins","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib81","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/03009740601153774","article-title":"Rheumatoid arthritis treatment and the risk of severe interstitial lung disease","volume":"36","author":"Wolfe","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.08.003_bib82","series-title":"ACR\/ARHP Annual Scientific Meeting 2007","article-title":"Rheumatoid arthritis, interstitial lung disease, mortality and anti-TNF therapy: results from the BSR Biologics Register (BSRBR)","author":"Dixon","year":"2007"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208001352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208001352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T23:58:29Z","timestamp":1545609509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017208001352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0049017208001352"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2008.08.003","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}